Cargando…

Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department

OBJECTIVES: Cardiac troponin-I (cTnI) is a representative marker of myocardial injury. Elevation of cTnI is frequently observed in patients with hypertensive crisis, but few studies have examined its prognostic significance in hypertensive crisis. We aimed to determine whether cTnI could predict all...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Woohyeun, Kim, Byung Sik, Kim, Hyun-Jin, Lee, Jun Hyeok, Shin, Jinho, Shin, Jeong-Hun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820824/
https://www.ncbi.nlm.nih.gov/pubmed/35112971
http://dx.doi.org/10.1080/07853890.2022.2034934
_version_ 1784646288457859072
author Kim, Woohyeun
Kim, Byung Sik
Kim, Hyun-Jin
Lee, Jun Hyeok
Shin, Jinho
Shin, Jeong-Hun
author_facet Kim, Woohyeun
Kim, Byung Sik
Kim, Hyun-Jin
Lee, Jun Hyeok
Shin, Jinho
Shin, Jeong-Hun
author_sort Kim, Woohyeun
collection PubMed
description OBJECTIVES: Cardiac troponin-I (cTnI) is a representative marker of myocardial injury. Elevation of cTnI is frequently observed in patients with hypertensive crisis, but few studies have examined its prognostic significance in hypertensive crisis. We aimed to determine whether cTnI could predict all-cause mortality in patients with hypertensive crisis visiting the emergency department (ED). METHODS: This observational study included patients aged ≥18 years who visited an ED between 2016 and 2019 for hypertensive crisis, defined as systolic blood pressure (BP) ≥180 mmHg and/or diastolic BP ≥110 mmHg. Among 6467 patients, 3938 who underwent a cTnI assay were analysed. RESULTS: Among the 3938 patients, 596 (15.1%) had cTnI levels above the 99th percentile upper reference limit (elevated cTnI >40 ng/L) and 600 (15.2%) had cTnI levels between the detection limit (≥10 ng/L) and the 99th percentile upper reference limit (detectable cTnI). The 3-year all-cause mortality in the elevated, detectable and undetectable cTnI groups were 41.6%, 36.5% and 12.8%, respectively. After adjusting for confounding variables, elevated cTnI patients (adjusted hazard ratio [HR], 2.01; 95% confidence interval [CI], 1.61–2.52) and detectable cTnI patients (adjusted HR, 1.64; 95% CI, 1.32–2.04) showed a significantly higher risk of 3-year all-cause mortality than did patients with undetectable cTnI. CONCLUSIONS: In patients with hypertensive crisis, elevated cTnI levels provide useful prognostic information and permit the early identification of patients with an increased risk of death. Moreover, putatively normal but detectable cTnI levels also significantly correlated with a higher risk of all-cause mortality. Intensive treatment and follow-up strategies are needed for patients with hypertensive crisis with elevated and detectable cTnI levels. KEY MESSAGES: 1. Cardiac troponin-I level was an independent prognostic factor for all-cause mortality in patients with hypertensive crisis. 2. Detectable but normal range cardiac troponin-I, which was considered clinically insignificant, also had a prognostic impact on all-cause mortality comparable to elevated cardiac troponin-I levels.
format Online
Article
Text
id pubmed-8820824
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88208242022-02-08 Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department Kim, Woohyeun Kim, Byung Sik Kim, Hyun-Jin Lee, Jun Hyeok Shin, Jinho Shin, Jeong-Hun Ann Med Cardiology & Cardiovascular Disorders OBJECTIVES: Cardiac troponin-I (cTnI) is a representative marker of myocardial injury. Elevation of cTnI is frequently observed in patients with hypertensive crisis, but few studies have examined its prognostic significance in hypertensive crisis. We aimed to determine whether cTnI could predict all-cause mortality in patients with hypertensive crisis visiting the emergency department (ED). METHODS: This observational study included patients aged ≥18 years who visited an ED between 2016 and 2019 for hypertensive crisis, defined as systolic blood pressure (BP) ≥180 mmHg and/or diastolic BP ≥110 mmHg. Among 6467 patients, 3938 who underwent a cTnI assay were analysed. RESULTS: Among the 3938 patients, 596 (15.1%) had cTnI levels above the 99th percentile upper reference limit (elevated cTnI >40 ng/L) and 600 (15.2%) had cTnI levels between the detection limit (≥10 ng/L) and the 99th percentile upper reference limit (detectable cTnI). The 3-year all-cause mortality in the elevated, detectable and undetectable cTnI groups were 41.6%, 36.5% and 12.8%, respectively. After adjusting for confounding variables, elevated cTnI patients (adjusted hazard ratio [HR], 2.01; 95% confidence interval [CI], 1.61–2.52) and detectable cTnI patients (adjusted HR, 1.64; 95% CI, 1.32–2.04) showed a significantly higher risk of 3-year all-cause mortality than did patients with undetectable cTnI. CONCLUSIONS: In patients with hypertensive crisis, elevated cTnI levels provide useful prognostic information and permit the early identification of patients with an increased risk of death. Moreover, putatively normal but detectable cTnI levels also significantly correlated with a higher risk of all-cause mortality. Intensive treatment and follow-up strategies are needed for patients with hypertensive crisis with elevated and detectable cTnI levels. KEY MESSAGES: 1. Cardiac troponin-I level was an independent prognostic factor for all-cause mortality in patients with hypertensive crisis. 2. Detectable but normal range cardiac troponin-I, which was considered clinically insignificant, also had a prognostic impact on all-cause mortality comparable to elevated cardiac troponin-I levels. Taylor & Francis 2022-02-03 /pmc/articles/PMC8820824/ /pubmed/35112971 http://dx.doi.org/10.1080/07853890.2022.2034934 Text en © 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cardiology & Cardiovascular Disorders
Kim, Woohyeun
Kim, Byung Sik
Kim, Hyun-Jin
Lee, Jun Hyeok
Shin, Jinho
Shin, Jeong-Hun
Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department
title Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department
title_full Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department
title_fullStr Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department
title_full_unstemmed Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department
title_short Clinical implications of cardiac troponin-I in patients with hypertensive crisis visiting the emergency department
title_sort clinical implications of cardiac troponin-i in patients with hypertensive crisis visiting the emergency department
topic Cardiology & Cardiovascular Disorders
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820824/
https://www.ncbi.nlm.nih.gov/pubmed/35112971
http://dx.doi.org/10.1080/07853890.2022.2034934
work_keys_str_mv AT kimwoohyeun clinicalimplicationsofcardiactroponiniinpatientswithhypertensivecrisisvisitingtheemergencydepartment
AT kimbyungsik clinicalimplicationsofcardiactroponiniinpatientswithhypertensivecrisisvisitingtheemergencydepartment
AT kimhyunjin clinicalimplicationsofcardiactroponiniinpatientswithhypertensivecrisisvisitingtheemergencydepartment
AT leejunhyeok clinicalimplicationsofcardiactroponiniinpatientswithhypertensivecrisisvisitingtheemergencydepartment
AT shinjinho clinicalimplicationsofcardiactroponiniinpatientswithhypertensivecrisisvisitingtheemergencydepartment
AT shinjeonghun clinicalimplicationsofcardiactroponiniinpatientswithhypertensivecrisisvisitingtheemergencydepartment